9EH Stock Overview
Through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Evolent Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.50 |
| 52 Week High | US$31.80 |
| 52 Week Low | US$12.50 |
| Beta | 1.59 |
| 11 Month Change | -48.77% |
| 3 Month Change | -45.65% |
| 1 Year Change | -51.92% |
| 33 Year Change | -49.60% |
| 5 Year Change | 47.93% |
| Change since IPO | -25.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9EH | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -41.6% | 26.8% | 1.1% |
| 1Y | -51.9% | -26.4% | 13.5% |
Return vs Industry: 9EH underperformed the German Healthcare Services industry which returned -25.7% over the past year.
Return vs Market: 9EH underperformed the German Market which returned 12.9% over the past year.
Price Volatility
| 9EH volatility | |
|---|---|
| 9EH Average Weekly Movement | 13.1% |
| Healthcare Services Industry Average Movement | 5.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9EH's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 9EH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,700 | Seth Blackley | www.evolent.com |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
Evolent Health, Inc. Fundamentals Summary
| 9EH fundamental statistics | |
|---|---|
| Market cap | €1.44b |
| Earnings (TTM) | -€97.83m |
| Revenue (TTM) | €2.31b |
0.7x
P/S Ratio-16.7x
P/E RatioIs 9EH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9EH income statement (TTM) | |
|---|---|
| Revenue | US$2.46b |
| Cost of Revenue | US$2.07b |
| Gross Profit | US$393.27m |
| Other Expenses | US$497.50m |
| Earnings | -US$104.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.91 |
| Gross Margin | 15.96% |
| Net Profit Margin | -4.23% |
| Debt/Equity Ratio | 48.9% |
How did 9EH perform over the long term?
See historical performance and comparison